Cloning and pharmacological studies have shown that glutamatergic rece
ptors can be divided in two classes (refer to Table 1): ionotropic rec
eptors including N-methyl-D-aspartate (NMDA) and non-NMDA subtypes, an
d the G-protein-coupled metabotropic receptors (glutamate metabotropic
receptor). There are two types of non-NMDA receptors: the AMPA/low-af
finity kainate receptor type (the AMPA receptors) activated by a speci
fic agonist, the alpha-amino-3-hydroxy-5-methyl-4-isoxalone propionate
(AMPA), and the high affinity kainate receptors. The vestibular nucle
i neurones are endowed with all these types of glutamatergic receptors
, which fits well with the fact that various afferents, including the
primary vestibular afferents, most probably use glutamate or aspartate
as a neurotransmitter. This article is aimed at summarising several p
ast studies of our group and some more recent data obtained in the in
vitro whole-brain preparation concerning the NMDA receptors of the cen
tral vestibular neurones. In that process, we will detail also many va
luable studies of other groups that had been devoted to the same topic
.